Chronic Kidney Disease Morbidity in Costa Rica, 2017-2023

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
 
Chronic Kidney Disease Morbidity in Costa Rica, 2017-2023

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Nora
Franceschini
Nora Franceschini noraf@unc.edu University of North Carolina Epidemiology & Genetics Chapel Hill United States *
Shelby Fisher ssfisher@unc.edu University of North Carolina Epidemiology Chapel Hill United States -
Lawrence Engel larry.engel@unc.edu University of North Carolina Epidemiology Chapel Hill United States -
Mariela Arias-Hidalgo MARIELA.ARIASHIDALGO@ucr.ac.cr University of Costa Rica Department of Physiology San Pedro de Montes de Oca Costa Rica -
Nicole Villegas González NICOLE.VILLEGAS@ucr.ac.cr University of Costa Rica Department of Environmental Health Liberia Costa Rica -
 
 
 
 
 
 
 
 
 
 

Chronic Kidney Disease (CKD) is a major public health problem in Costa Rica, but current estimates of incident CKD and its regional variation are not publicly available. In 2017, the Costa Rican government established a CKD registry and mandated reporting of all clinically diagnosed CKD in the country. We used this registry to estimate the annual distributions of newly reported CKD in Costa Rica by age, sex, and geographical region. 

We used the CKD registry data collected from 2017 to 2023 to calculate the distribution of newly reported CKD cases overall and by province, and within sex (male and female) and age groups (0-39, 40-64, 65 or more years), which were standardized to the national population based on the 2022 census.

Figure. Geographic differences in age- and sex-adjusted incident rates of chronic kidney disease in Costa Rica

As expected, CKD incidence was higher in women than in men and increased with age, being the highest among individuals 65 years or older. However, patterns of CKD incidence by sex and age varied markedly across provinces. Overall, CKD incidence was higher in women than in men and increased with age, being the highest among individuals 65 years or older. Within geographic regions, CKD incidence varied by sex and age categories across provinces. Limón and Guanacaste, two coastal provinces, displayed, by far, the highest overall and age- and sex-specific incidence rates of CKD in the country (Figure).  Among individuals in the younger age group (0 to 39 years), the rates of CKD were higher among men than women in Guanacaste (21.4 vs. 9.1 per 100,000 persons, respectively) but were higher among women than men in Limón (30.1 vs. 12.4 per 100,000 persons, respectively). 

There are large geographic differences in CKD incidence across Costa Rica, with substantial variation by sex and age. Our findings confirm the higher CKD incidence among younger men in Guanacaste, supporting observations of an ongoing epidemic of CKD of unknown etiology in this region. They also indicate a high incidence of CKD in Limón, especially among women. This information can help local efforts to identify the potential causes of CKD among men and women and to allocate resources to treat and prevent CKD in areas with high CKD incidence.

Kewords